Vaxart
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!About VXRT
Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV).
CEOSteven Lo
CEOSteven Lo
Employees115
Employees115
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2004
Founded2004
Employees115
Employees115
VXRT Key Statistics
Market cap158.47M
Market cap158.47M
Price-Earnings ratio-2.97
Price-Earnings ratio-2.97
Dividend yield—
Dividend yield—
Average volume2.19M
Average volume2.19M
High today—
High today—
Low today—
Low today—
Open price$0.6551
Open price$0.6551
Volume0.00
Volume0.00
52 Week high$0.8449
52 Week high$0.8449
52 Week low$0.2606
52 Week low$0.2606
Stock Snapshot
With a market cap of 158.47M, Vaxart(VXRT) trades at $0.66. The stock has a price-to-earnings ratio of -2.97.
On 2026-01-23, Vaxart(VXRT) stock opened at $0.66, reached a high of —, and a low of —.
Vaxart(VXRT) shares are trading with a volume of 0, against a daily average of 2.19M.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.84 and a 52-week low of $0.26.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.84 and a 52-week low of $0.26.
People also own
Based on the portfolios of people who own VXRT. This list is generated using Robinhood data, and it’s not a recommendation.